National Comprehensive Cancer Network

Subscriptions & Products
For Patients

About NCCN

Acute Myeloid Leukemia Panel - Disclosures as of 9/2/2010

View NCCN Management Team Disclosures | View NCCN Guidelines Staff Disclosures | View NCCN ORP Staff Disclosures

Panel Member Clinical Research Support Advisory Boards, Speakers Bureau, Expert Witness, or Consultant Patent, Equity, or Royalty Other Date Completed

Camille N. Abboud, MD

None

Genzyme Corporation;
GlaxoSmithKline;
Novartis Pharmaceuticals Corporation

None

None

5/5/2010

Jessica Altman, MD

OSI Pharmaceuticals, Inc.;
Lilly Pharmaceuticals

Genzyme Corporation;
Novartis Pharmaceuticals Corporation

None

None

4/27/2010

Frederick R. Appelbaum, MD

None

None

None

None

10/28/2009

Daniel A. Arber, MD

       

Pending

Steven E. Coutre, MD

Cephalon, Inc.;
Wyeth Pharmaceuticals

Genzyme Corporation

None

None

3/26/2010

Lloyd E. Damon, MD

None

None

None

None

4/14/2010

James M. Foran, MD

Eisai Inc.;
Genzyme Corporation;
Medarex, Inc.

Celgene Corporation;
Sunesis Pharmaceuticals, Inc.

None

None

2/9/2010

Lauren Gallagher, RPh, PhD

None

None

None

None

8/23/2010

Salil Goorha, MD

None

None

None

None

9/28/2009

Kristina M. Gregory, RN, MSN, OCN

None

None

None

None

8/30/2010

Rashmi Kumar, PhD

None

None

None

None

7/15/2010

Jeffrey Lancet, MD

None

Eisai Inc.;
Genzyme Corporation;
Novartis Pharmaceuticals Corporation;
Sunesis Pharmaceuticals, Inc.

None

None

3/3/2010

Lori J. Maness, MD

None

None

None

None

10/28/2009

Guido Marcucci, MD

None

None

None

None

9/28/2009

Peter Maslak, MD

None

None

None

None

10/14/2009

Joan S. McClure, MS

None

None

None

None

7/18/2010

Michael M. Millenson, MD, FACP

None

Amgen Inc.;
Celgene Corporation;
GlaxoSmithKline

None

sanofi-aventis U.S.

12/8/2009

Joseph O. Moore, MD

Genentech, Inc.;
Novartis Pharmaceuticals Corporation

Amgen Inc.;
Genentech, Inc.;
Novartis Pharmaceuticals Corporation

None

None

10/28/2009

Margaret R. O'Donnell, MD

National Cancer Institute

Anti-soma

None

None

5/24/2010

Farhad Ravandi, MD

Bayer HealthCare;
Cephalon, Inc.;
Eisai Inc.

Bayer HealthCare;
Cephalon, Inc.;
Eisai Inc.;
Genzyme Corporation;
Novartis Pharmaceuticals Corporation

None

None

10/28/2009

Paul J. Shami, MD

Genzyme Corporation

Novartis Pharmaceuticals Corporation

JSK Therapeutics Inc.

None

12/10/2009

B. Douglas Smith, MD

Genzyme Corporation;
Novartis Pharmaceuticals Corporation;
Calistoga;
Infinity;
Infinity;
Merck Serono;
Synta Pharmaceuticals Corp.

Bristol-Myers Squibb Company;
Celgene Corporation;
Novartis Pharmaceuticals Corporation

None

None

3/23/2010

Richard M. Stone, MD

Novartis Pharmaceuticals Corporation

Celgene Corporation;
Cephalon, Inc.;
Genzyme Corporation;
Merck & Co., Inc.

None

None

2/9/2010

Stephen A. Strickland, MD

GlaxoSmithKline;
Novartis Pharmaceuticals Corporation;
Cyclacel Pharmaceuticals;
Sunesis Pharmaceuticals, Inc.

Genzyme Corporation

None

None

10/29/2009

Martin S. Tallman, MD

None

Genzyme Corporation

None

None

10/28/2009

Eunice S. Wang, MD

None

None

None

None

12/21/2009

 

NCCN Website Supporters